MORE VIDEOS
Jelajahi lebih banyak

Video terbaru

Primary peritoneal carcinomatosis
Primary peritoneal carcinomatosis administrator 1 Tampilan • 2 bertahun-tahun yang lalu

Patient with pelvic pain. MR and CT images demonstrate extensive thickening and nodularity of the omentum and peritoneum with ascites, but no discrete ovarian mass lesion. This was ultimately concluded to represent primary peritoneal carcinomatosis.

For more, visit our website at http://ctisus.com

Waterfalls Webinar Dr. Torrent & Dr. Quénet: Peritoneal Carcinomatosis
Waterfalls Webinar Dr. Torrent & Dr. Quénet: Peritoneal Carcinomatosis administrator 0 Tampilan • 2 bertahun-tahun yang lalu

Welcome to the Quironsalud Master Class. Today Drs. Juanjo Torrent and François Quénet are going to talk about the peritoneal carcinomatosis.

Dr. Torrent is an expert in minimally invasive oncological surgery. His area of specialization is focused on the surgical treatment of peritoneal carcinomatosis of ovarian origin, and he is the main investigator in Spain of clinical studies of European scope on the treatment of peritoneal carcinomatosis by cytoreduction surgery.

Dr. Quénet is an expert in digestive and hepato-biliary surgery. He directs peritoneal carcinomatosis treatment programs through surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC).

He is the principal investigator of a trial dedicated to research on HIPEC and colorectal cancer.
Peritoneal metastasis
Peritoneal metastasis administrator 3 Tampilan • 2 bertahun-tahun yang lalu

This is a short video for the viewers to understand how does the spread of cancer inside the abdomen look.Once the cancer cells get access to the abdominal cavity they follow the flow of peritoneal fluid and get deposited on the peritoneum. The deposits can vary in size and shape. The spread may also be associated with malignant fluid in the abdomen. Most of these deposits are not very thick and hence they are not picked up by CT/PET scans.
Cancer survivor on how to advocate for yourself as a patient
Cancer survivor on how to advocate for yourself as a patient administrator 0 Tampilan • 2 bertahun-tahun yang lalu

Amanda Kabbabe was 24 when she was diagnosed with a rare form of ovarian cancer. Now, she's sharing her story to help others. Kabbabe and CBS News medical contributor Dr. Tara Narula joined CBSN AM to talk about patient advocacy.
Peritoneal Carcinomatosis: The Medical Oncologist's Perspective
Peritoneal Carcinomatosis: The Medical Oncologist's Perspective administrator 2 Tampilan • 2 bertahun-tahun yang lalu

Dr. Heloisa Soares, assistant professor in the Division of Oncology, discusses the treatment of peritoneal carcinomatosis in the oncology setting.
Multidisciplinary management of peritoneal carcinomatosis from colorectal cancer: New perspectives
Multidisciplinary management of peritoneal carcinomatosis from colorectal cancer: New perspectives administrator 5 Tampilan • 2 bertahun-tahun yang lalu

Drs. Mario Dicato and Eric Van Cutsem, along with Dr. Josep Tabernero, chaired the ESMO 15th World Congress on Gastrointestinal Cancer which was held in Barcelona, Spain, 3-6 July 2013. This webcast includes most of the clinical presentations from this premier meeting. Didactic lectures, case studies, debates, and cutting-edge research from expert international faculty comprise the outstanding content of the World Congress.

Earn accreditation for this activity at the following location:
http://elc.imedex.com/ELC/Acti....vity-Detail.aspx?act

© 2013 Imedex, LLC.

Paclitaxel in elderly women with ovarian, primary peritoneal or fallopian tube cancer
Paclitaxel in elderly women with ovarian, primary peritoneal or fallopian tube cancer administrator 1 Tampilan • 2 bertahun-tahun yang lalu

Dr Tew speaks with ecancertv at SIOG 2016 about the gynaecologic oncology group (GOG) study into geriatric assessment and outcomes with carboplatin and weekly low-dose Paclitaxel in elderly women with ovarian, primary peritoneal or fallopian tube cancer.
Peritoneal Cancer Awareness Month - September
Peritoneal Cancer Awareness Month - September administrator 2 Tampilan • 2 bertahun-tahun yang lalu

Peritoneal cancer is a rare and aggressive cancer. It is sometimes called the "silent killer" because it usually does not cause symptoms until it is in advanced stages. But there is hope. It is possible to treat.
Although it is rare, it is sometimes seen as early as 25 years old.
Symptoms include pain in the abdomen, pelvic area, and back.
If you experience any of these symptoms, see your doctor as soon as possible. September is Peritoneal Cancer Awareness Month. If you have any questions or concerns about this video, please comment below.
#PeritonealCancer #AppendixCancer #OvaryCancer #PeritonealCancerAwarenessMonth
Understanding Peritoneal Cancer
Understanding Peritoneal Cancer administrator 1 Tampilan • 2 bertahun-tahun yang lalu

Peritoneal cancer is a rare type of cancer that develops in the thin layer of tissues that line the abdomen. Dr. Sanjeev Kumar https://bit.ly/36JMvh4 emphasizes that with the use of advanced technology, HIPEC surgery along with chemotherapy and technical expertise, not only peritoneal cancer but many other types of cancer can be successfully treated. Detect early. Correct early. Call 8860 444 888 and book your consultation at Max Institute of Cancer Care. #NidarrHamesha #WorldCancerDay

Advances in the treatment of peritoneal metastases in gastric cancer
Advances in the treatment of peritoneal metastases in gastric cancer administrator 0 Tampilan • 2 bertahun-tahun yang lalu

Dr Geraldo Alves speaks to ecancer at the 2019 ecancer-Oncosalud Symposium of Molecular Clinical Oncology in Peru about the main advances in the treatment of peritoneal metastases in gastric cancer.

He reports the results from one study in which patients treated with a combination of hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery survived longer, compared to patients treated with cytoreductive surgery alone.

Dr Alves also describes further trials, including the
PERISCOPE II and GASTRIPEC studies, that are investigating the effect of perioperative chemotherapy plus HIPEC in high-risk patients.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php
Showing 3234 out of 3235